申请人:Galley Guido
公开号:US20090036420A1
公开(公告)日:2009-02-05
The present invention relates to methods of treating CNS disorders with a compound of formula I
wherein
X, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, and R
8
are as defined in the specification and pharmaceutically acceptable acid addition salts thereof.
本发明涉及使用式I中的化合物治疗中枢神经系统疾病的方法,其中X、R1、R2、R3、R4、R5、R6、R7和R8如说明书中所定义,并且包括药学上可接受的酸盐。